Literature DB >> 14532190

Molecular evidence of persistent echovirus 13 meningoencephalitis in a patient with relapsed lymphoma after an outbreak of meningitis in 2000.

Christine Archimbaud1, Jean-Luc Bailly, Martine Chambon, Olivier Tournilhac, Philippe Travade, Hélène Peigue-Lafeuille.   

Abstract

Enteroviral meningoencephalitis was diagnosed in a patient with an immunodeficiency syndrome acquired after treatment with rituximab for a relapsed primary B-cell lymphoma. A second meningoencephalitic episode was diagnosed 6 months later and was successfully treated with a combination of immunoglobulins and pleconaril. The infection was persistent since the enterovirus genome was detected in five sequential specimens of cerebrospinal fluid collected over 9 months. An echovirus 13 isolate was isolated in the first three samples. The viral sequence encoding the VP1 capsid protein of the three isolates was determined and was compared with that of four control viruses. The virus isolates recovered from the patient shared >99% nucleotide sequence similarity with one another. In a phylogenetic tree, they were directly related to a control virus obtained from a patient hospitalized in 2000 during an outbreak of enterovirus meningitis. The epidemiological origin of a chronic echovirus infection in a patient with immune deficiency suggests that the echovirus had been continuously circulating in the general population after the outbreak that had revealed its emergence.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14532190      PMCID: PMC254333          DOI: 10.1128/JCM.41.10.4605-4610.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  28 in total

1.  Chronic enteroviral meningo-encephalitis in X-linked agammaglobulinaemia: favourable response to anti-enteroviral treatment.

Authors:  M Schmugge; R Lauener; W Bossart; R A Seger; T Güngör
Journal:  Eur J Pediatr       Date:  1999-12       Impact factor: 3.183

2.  Enteroviral meningoencephalitis in X-linked agammaglobulinemia: intensive immunoglobulin therapy and sequential viral detection in cerebrospinal fluid by polymerase chain reaction.

Authors:  P Quartier; S Foray; J L Casanova; I Hau-Rainsard; S Blanche; A Fischer
Journal:  Pediatr Infect Dis J       Date:  2000-11       Impact factor: 2.129

3.  Viral meningitis associated with increase in echovirus type 13.

Authors: 
Journal:  Commun Dis Rep CDR Wkly       Date:  2000-08-04

4.  Enteroviruses can persist with or without active viral replication in cardiac tissue of patients with end-stage ischemic or dilated cardiomyopathy.

Authors:  L Andréoletti; T Bourlet; D Moukassa; L Rey; D Hot; Y Li; V Lambert; B Gosselin; J F Mosnier; C Stankowiak; P Wattré
Journal:  J Infect Dis       Date:  2000-09-08       Impact factor: 5.226

5.  Genomic variations in echovirus 30 persistent isolates recovered from a chronically infected immunodeficient child and comparison with the reference strain.

Authors:  J L Bailly; M Chambon; C Henquell; J Icart; H Peigue-Lafeuille
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

6.  Successful treatment of enterovirus infection with the use of pleconaril in 2 infants with severe combined immunodeficiency.

Authors:  A Nowak-Wegrzyn; W Phipatanakul; J A Winkelstein; M S Forman; H M Lederman
Journal:  Clin Infect Dis       Date:  2000-12-11       Impact factor: 9.079

7.  Nosocomial transmission of echovirus 30: molecular evidence by phylogenetic analysis of the VP1 encoding sequence.

Authors:  J L Bailly; A Béguet; M Chambon; C Henquell; H Peigue-Lafeuille
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

8.  Stable enterovirus 5' nontranslated region over a 7-year period in a patient with agammaglobulinemia and chronic infection.

Authors:  J J Dunn; J R Romero; R Wasserman; H A Rotbart
Journal:  J Infect Dis       Date:  2000-07-06       Impact factor: 5.226

9.  Circulation of enteroviruses and persistence of meningitis cases in the winter of 1999-2000.

Authors:  M Chambon; C Archimbaud; J L Bailly; C Henquell; C Regagnon; F Charbonné; H Peigue-Lafeuille
Journal:  J Med Virol       Date:  2001-10       Impact factor: 2.327

10.  Treatment of potentially life-threatening enterovirus infections with pleconaril.

Authors:  H A Rotbart; A D Webster
Journal:  Clin Infect Dis       Date:  2001-01-15       Impact factor: 9.079

View more
  6 in total

1.  Widespread circulation of echovirus type 13 demonstrated by increased seroprevalence in Toyama, Japan, between 2000 and 2003.

Authors:  Masae Iwai; Hiromu Yoshida; Mayumi Obara; Eiji Horimoto; Kazuya Nakamura; Takenori Takizawa; Takeshi Kurata; Mineyuki Mizuguchi; Tohru Daikoku; Kimiyasu Shiraki
Journal:  Clin Vaccine Immunol       Date:  2010-03-24

2.  Isolation and identification of enteroviruses from sewage and sewage-contaminated water in Lagos, Nigeria.

Authors:  Johnson Adekunle Adeniji; Temitope Oluwasegun Cephas Faleye
Journal:  Food Environ Virol       Date:  2014-02-25       Impact factor: 2.778

Review 3.  The role of prolonged viral gastrointestinal infections in the development of immunodeficiency-related enteropathy.

Authors:  Annick A J M van de Ven; David P Hoytema van Konijnenburg; Annemarie M J Wensing; Joris M van Montfrans
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

4.  Molecular epidemiology of echoviruses 11 and 13, based on an environmental surveillance conducted in Toyama Prefecture, 2002-2003.

Authors:  Masae Iwai; Hiromu Yoshida; Kumiko Matsuura; Tsuguto Fujimoto; Hiroyuki Shimizu; Takenori Takizawa; Yoshiyuki Nagai
Journal:  Appl Environ Microbiol       Date:  2006-09       Impact factor: 4.792

5.  Prospective identification of enteroviruses involved in meningitis in 2006 through direct genotyping in cerebrospinal fluid.

Authors:  Audrey Mirand; Cécile Henquell; Christine Archimbaud; Martine Chambon; Françoise Charbonne; Hélène Peigue-Lafeuille; Jean-Luc Bailly
Journal:  J Clin Microbiol       Date:  2007-10-31       Impact factor: 5.948

Review 6.  Risk of infection in patients with lymphoma receiving rituximab: systematic review and meta-analysis.

Authors:  Simone Lanini; Aoife C Molloy; Paul E Fine; Archibald G Prentice; Giuseppe Ippolito; Christopher C Kibbler
Journal:  BMC Med       Date:  2011-04-12       Impact factor: 8.775

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.